Trial ID: | L0972 |
Source ID: | NCT00816465
|
Associated Drug: |
Hoodia gordonii
|
Title: |
Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)
|
Acronym: |
--
|
Status: |
Not recruiting
|
Study Results: |
No Results Available
|
Results: |
--
|
Conditions: |
Non-Alcoholic Fatty Liver Disease
|
Interventions: |
Dietary Supplement: Hoodia gordonii;Other: Placebo
|
Outcome Measures: |
decreased insulin resistance;safetyreduced hepatic injury;reduced weight/BMI/abdominal circumference
|
Sponsor/Collaborators: |
Hadassah Medical Organization
|
Gender: |
All
|
Age: |
18 Years65 Years
|
Phases: |
Phase 1
|
Enrollment: |
20
|
Study Type: |
Interventional
|
Study Designs: |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
|
Start Date: |
31/12/2008
|
Completion Date: |
--
|
Results First Posted: |
--
|
Last Update Posted: |
19 February 2015
|
Locations: |
Israel
|
URL: |
http://clinicaltrials.gov/show/NCT00816465
|